CARLSBAD, Calif.--(BUSINESS WIRE)--Feb. 28, 2006--Invitrogen Corporation (Nasdaq: IVGN) today announced results for its fourth quarter and full-year ended December 31, 2005. Revenues for the fourth quarter were $325.3 million, an increase of 24% over the $262.2 million reported for the fourth quarter of 2004. Net income for the fourth quarter was $49.6 million versus $30.5 million for the same quarter in 2004, an increase of 63%. Earnings per share for the fourth quarter of 2005 increased 58% to $0.87 per share, as compared to $0.55 per share reported in the fourth quarter of 2004.
